当前位置:首页 - 行情中心 - 海利生物(603718) - 财务分析 - 现金流量表

海利生物

(603718)

  

流通市值:45.82亿  总市值:46.29亿
流通股本:6.49亿   总股本:6.56亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金160,394,877.74119,075,211.0446,344,582.44229,033,898.88
  收到其他与经营活动有关的现金19,886,061.9419,636,166.883,640,860.9521,306,477.83
  经营活动现金流入小计180,280,939.68138,711,377.9249,985,443.39250,340,376.71
  购买商品、接受劳务支付的现金32,053,326.8513,662,246.035,136,427.5947,366,102.87
  支付给职工以及为职工支付的现金45,285,917.143,130,285.3124,656,394.9371,116,740.91
  支付的各项税费29,819,160.7123,899,616.1316,216,806.7823,891,564.33
  支付其他与经营活动有关的现金36,350,779.4619,898,553.639,575,722.161,492,877.88
  经营活动现金流出小计143,509,184.12100,590,701.155,585,351.4203,867,285.99
  经营活动产生的现金流量净额36,771,755.5638,120,676.82-5,599,908.0146,473,090.72
二、投资活动产生的现金流量:
  收回投资收到的现金292,775,105.22224,053,774.46140,014,0001,163,227,548.7
  取得投资收益收到的现金1,080,080.84916,129.69761,376.48199,664,688.15
  处置固定资产、无形资产和其他长期资产收回的现金净额310,541.18305,000--
  投资活动现金流入小计294,165,727.24225,274,904.15140,775,376.481,362,892,236.85
  购建固定资产、无形资产和其他长期资产支付的现金6,363,549.396,783,988.984,140,688.988,389,958
  投资支付的现金290,616,800227,064,000117,433,000538,000,000
  取得子公司及其他营业单位支付的现金21,507,071.4621,507,071.46-892,928.54768,330,381.96
  支付其他与投资活动有关的现金12,392.22--9,833,595.23
  投资活动现金流出小计318,499,813.07255,355,060.44120,680,760.441,324,553,935.19
  投资活动产生的现金流量净额-24,334,085.83-30,080,156.2920,094,616.0438,338,301.66
三、筹资活动产生的现金流量:
  取得借款收到的现金3,000,000--837,990,640.47
  筹资活动现金流入平衡项目0--0
  筹资活动现金流入小计3,000,000--837,990,640.47
  偿还债务支付的现金---688,413,429
  分配股利、利润或偿付利息支付的现金51,316,200.15--21,573,173.7
  支付其他与筹资活动有关的现金11,606,075.4212,611,233.4510,517,452.911,712,442.1
  筹资活动现金流出小计62,922,275.5712,611,233.4510,517,452.91711,699,044.8
  筹资活动产生的现金流量净额-59,922,275.57-12,611,233.45-10,517,452.91126,291,595.67
四、汇率变动对现金及现金等价物的影响-1,036,317.36-700,708.9-236,827.9610,304,326.17
五、现金及现金等价物净增加额-48,520,923.2-5,271,421.823,740,427.16221,407,314.22
  加:期初现金及现金等价物余额358,500,504.83358,500,504.83358,500,504.83137,093,190.61
  期末现金及现金等价物余额309,979,581.63353,229,083.01362,240,931.99358,500,504.83
补充资料:
  净利润-31,979,342.76-181,635,596.01
  资产减值准备---3,714,782.36
  固定资产和投资性房地产折旧-2,643,853.48-21,744,102.35
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-2,643,853.48-21,744,102.35
  无形资产摊销-3,958,260.4-13,051,973.41
  长期待摊费用摊销-717,704.75-1,836,753.87
  处置固定资产、无形资产和其他长期资产的损失--223,211.51--
  固定资产报废损失-5,477.23-706,224.28
  公允价值变动损失--1,501,099.14-12,761,890.33
  财务费用-1,472,800.39--4,813,340.39
  投资损失--223,930.93--158,406,545.28
  递延所得税--565,778.81-16,669,594.76
  其中:递延所得税资产减少-3,175.15-17,867,457.93
    递延所得税负债增加--568,953.96--1,197,863.17
  存货的减少--6,742,468.3-9,166,404.12
  经营性应收项目的减少-5,991,710.99--19,406,503.96
  经营性应付项目的增加--2,702,503.46--59,206,983.76
  其他---20,452,326.33
  现金的期末余额-353,229,083.01-358,500,504.83
  减:现金的期初余额-358,500,504.83-137,093,190.61
  现金及现金等价物的净增加额--5,271,421.82-221,407,314.22
公告日期2025-10-302025-08-282025-04-222025-04-22
审计意见(境内)标准无保留意见
TOP↑